Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China

Authors: Yi Zhou, Justin B Echouffo-Tcheugui, Jian-jun Gu, Xiao-nan Ruan, Gen-ming Zhao, Wang-hong Xu, Li-ming Yang, Hong Zhang, Hua Qiu, K M Venkat Narayan, Qiao Sun

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Few population-based studies have examined the relationship between glycemic status and chronic kidney disease (CKD) in China. We examined the prevalence of CKD across categories of glycemia [diagnosed diabetes, undiagnosed diabetes (fasting plasma glucose [FPG] ≥ 126 mg/dL), prediabetes (FPG 100–126 mg/dL) and normal glycemia (FPG <100 mg/dL)] among Chinese adults and assessed the relative contribution of dysglycemia (prediabetes and/or diabetes) to the burden of CKD.

Methods

5,584 Chinese adults aged 20–79 years were selected from the Pudong New Area of Shanghai through a multistage random sampling. Demographic and lifestyle characteristics, anthropometry and blood pressure were measured. Biochemical assays included FPG, serum creatinine and lipids, urinary creatinine and albumin. Prevalence of albuminuria [urine albumin-to-creatinine ratio (ACR) ≥ 30 mg/g], decreased kidney function and CKD (either decreased kidney function or albuminuria) across levels of glycemia were estimated.

Results

The prevalence of albuminuria, decreased kidney function and CKD each increased with higher glycemic levels (P < 0.001). Based on the MDRD Study equation, the unadjusted CKD prevalence was 30.9%, 28.5%, 14.1% and 9.2% in those with diagnosed diabetes, undiagnosed diabetes, prediabetes and normoglycemia, respectively. The corresponding age-, gender- and hypertension-adjusted CKD prevalence were 25.8%, 25.0%, 12.3% and 9.1%, respectively. In a multivariable analysis, the factors associated with CKD were hypertension (Odds ratio [OR] 1.70, 95% confidence interval [CI]: 1.42-2.03), dysglycemia (OR 1.65, 95% CI: 1.39-1.95), female gender (OR 1.48, 95% CI: 1.25-1.75), higher triglycerides (OR 1.14, 95% CI: 1.08-1.20 per mmol/L), higher body mass index (OR 1.08, 95% CI: 1.05-1.10 per kg/m2), and older age (OR 1.02, 95% CI: 1.01 -1.03 per year). The population attributable risks (PARs) associated with diabetes, prediabetes, dysglycemia (diabetes and prediabetes) and hypertension were 18.4%, 19.7%, 30.3% and 44.5% for CKD as defined by the MDRD study equation, and 15.8%, 24.4%, 29.2% and 10.0% with the CKD-EPI equation. Estimates of prevalence and ORs of the relative contribution of various risk factors to CKD obtained with the CKD-EPI equation were similar.

Conclusions

As much as 30% of the CKD burden may be associated with dysglycemia among Chinese adults, independent of age, gender and hypertension status. Prevention and control of diabetes and prediabetes should be a high priority in reducing the CKD burden in China.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: global dimension and perspectives. Lancet. 2013, 382 (9888): 260-272. 10.1016/S0140-6736(13)60687-X.CrossRefPubMed Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: global dimension and perspectives. Lancet. 2013, 382 (9888): 260-272. 10.1016/S0140-6736(13)60687-X.CrossRefPubMed
2.
go back to reference Hunsicker LG: The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol. 2004, 15 (5): 1363-1364. 10.1097/01.ASN.0000126069.68755.99.CrossRefPubMed Hunsicker LG: The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol. 2004, 15 (5): 1363-1364. 10.1097/01.ASN.0000126069.68755.99.CrossRefPubMed
3.
go back to reference Whiting DR, Guariguata L, Weil C, Shaw J: IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011, 94 (3): 311-321. 10.1016/j.diabres.2011.10.029.CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J: IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011, 94 (3): 311-321. 10.1016/j.diabres.2011.10.029.CrossRefPubMed
4.
go back to reference Ronald P, Abhishek K, Mary A, Lynar L: Chronic kidney disease and diabetes. Maturitas. 2012, 2 (71): 94-103. Ronald P, Abhishek K, Mary A, Lynar L: Chronic kidney disease and diabetes. Maturitas. 2012, 2 (71): 94-103.
5.
go back to reference Hallan SI, Stevens P: Screening for chronic kidney disease: which strategy?. J Nephrol. 2010, 23 (2): 147-155.PubMed Hallan SI, Stevens P: Screening for chronic kidney disease: which strategy?. J Nephrol. 2010, 23 (2): 147-155.PubMed
6.
go back to reference Kidney Disease Outcomes Initiative: KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007, 49 (2 Suppl 2): S12-S154. Kidney Disease Outcomes Initiative: KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007, 49 (2 Suppl 2): S12-S154.
7.
go back to reference Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007, 72 (3): 247-259. 10.1038/sj.ki.5002343.CrossRefPubMed Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007, 72 (3): 247-259. 10.1038/sj.ki.5002343.CrossRefPubMed
8.
go back to reference Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D: Glycemic status and development of kidney disease: the Framingham heart study. Diabetes Care. 2005, 28 (10): 2436-2440. 10.2337/diacare.28.10.2436.CrossRefPubMed Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D: Glycemic status and development of kidney disease: the Framingham heart study. Diabetes Care. 2005, 28 (10): 2436-2440. 10.2337/diacare.28.10.2436.CrossRefPubMed
9.
go back to reference Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012, 379 (9818): 815-822. 10.1016/S0140-6736(12)60033-6.CrossRefPubMed Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012, 379 (9818): 815-822. 10.1016/S0140-6736(12)60033-6.CrossRefPubMed
10.
go back to reference Zhou Y, Sun Q, Ruan XN, Xu WH, Zhao GM, Gu JJ, Yang LM, Fu XJ, Bai Y, Zhang H, Qiu H: Epidemiology of chronic kidney disease in adults of Pudong New Area, Shanghai. Chin J Nephrol. 2011, 27 (7): 504-510. (in Chinese) Zhou Y, Sun Q, Ruan XN, Xu WH, Zhao GM, Gu JJ, Yang LM, Fu XJ, Bai Y, Zhang H, Qiu H: Epidemiology of chronic kidney disease in adults of Pudong New Area, Shanghai. Chin J Nephrol. 2011, 27 (7): 504-510. (in Chinese)
11.
go back to reference Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, Li G, Jiao S, Liu Z, Liang W, Wang H: Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008, 51 (3): 373-384. 10.1053/j.ajkd.2007.11.009.CrossRefPubMed Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, Li G, Jiao S, Liu Z, Liang W, Wang H: Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008, 51 (3): 373-384. 10.1053/j.ajkd.2007.11.009.CrossRefPubMed
12.
go back to reference Wang H, Zhang L, Lv J: Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl. 2005, 94: S63-S67.CrossRefPubMed Wang H, Zhang L, Lv J: Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl. 2005, 94: S63-S67.CrossRefPubMed
13.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China NationalDiabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China NationalDiabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
14.
go back to reference Watanabe Y, Fujii H, Aoki K, Kanazawa Y, Miyakawa T: A cross-sectional survey of chronic kidney disease and diabetic kidney disease in Japanese type 2 diabetic patients at four urban diabetes clinics. Intern Med. 2009, 48 (6): 411-414. 10.2169/internalmedicine.48.1691.CrossRefPubMed Watanabe Y, Fujii H, Aoki K, Kanazawa Y, Miyakawa T: A cross-sectional survey of chronic kidney disease and diabetic kidney disease in Japanese type 2 diabetic patients at four urban diabetes clinics. Intern Med. 2009, 48 (6): 411-414. 10.2169/internalmedicine.48.1691.CrossRefPubMed
15.
go back to reference Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR, CDC CKD Surveillance Team: Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010, 5 (4): 673-682. 10.2215/CJN.07891109.CrossRefPubMedPubMedCentral Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR, CDC CKD Surveillance Team: Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010, 5 (4): 673-682. 10.2215/CJN.07891109.CrossRefPubMedPubMedCentral
16.
go back to reference van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, Gussekloo J, Dekker FW, Groeneveld Y: Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Br J Gen Pract. 2010, 60 (581): 884-890. 10.3399/bjgp10X544041.CrossRefPubMedPubMedCentral van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, Gussekloo J, Dekker FW, Groeneveld Y: Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Br J Gen Pract. 2010, 60 (581): 884-890. 10.3399/bjgp10X544041.CrossRefPubMedPubMedCentral
17.
go back to reference Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Wang W, Zuo Y, Gu H, Xiang K: Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant. 2009, 24 (12): 3724-3731. 10.1093/ndt/gfp349.CrossRefPubMed Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Wang W, Zuo Y, Gu H, Xiang K: Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant. 2009, 24 (12): 3724-3731. 10.1093/ndt/gfp349.CrossRefPubMed
18.
go back to reference Xu WH, Ruan XN, Fu XJ, Zhu QL, Zhang H, Bai Y, Wu HY, Zhou Y, Qiu H, Sun Q, Jiang QW, Yang LM, Gu JJ, Zhao GM: Prevalence of the metabolic syndrome in Pudong New Area of Shanghai using three proposed definitions among Chinese adults. BMC Public Health. 2010, 10: 246-10.1186/1471-2458-10-246.CrossRefPubMedPubMedCentral Xu WH, Ruan XN, Fu XJ, Zhu QL, Zhang H, Bai Y, Wu HY, Zhou Y, Qiu H, Sun Q, Jiang QW, Yang LM, Gu JJ, Zhao GM: Prevalence of the metabolic syndrome in Pudong New Area of Shanghai using three proposed definitions among Chinese adults. BMC Public Health. 2010, 10: 246-10.1186/1471-2458-10-246.CrossRefPubMedPubMedCentral
19.
go back to reference National Institute of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report. National institutes of health. Obes Res. 1998, 6 Suppl 2: 51S-209S. National Institute of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--the evidence report. National institutes of health. Obes Res. 1998, 6 Suppl 2: 51S-209S.
20.
go back to reference Cooperative Meta-analysis Group of China Obesity Task Force: Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol. 2002, 23 (1): 5-10. Cooperative Meta-analysis Group of China Obesity Task Force: Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol. 2002, 23 (1): 5-10.
21.
go back to reference American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012, 35 (Suppl 1): S64-S71.CrossRef American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012, 35 (Suppl 1): S64-S71.CrossRef
22.
go back to reference Lord GM, Tagore R, Cook T, Gower P, Pusey CD: Nephropathy caused by Chinese herbs in the UK. Lancet. 1999, 354 (9177): 481-482. 10.1016/S0140-6736(99)03380-2.CrossRefPubMed Lord GM, Tagore R, Cook T, Gower P, Pusey CD: Nephropathy caused by Chinese herbs in the UK. Lancet. 1999, 354 (9177): 481-482. 10.1016/S0140-6736(99)03380-2.CrossRefPubMed
23.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral
24.
go back to reference Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: KDIGO controversies conference. Kidney Int. 2011, 80 (1): 17-28. 10.1038/ki.2010.483.CrossRefPubMed Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: KDIGO controversies conference. Kidney Int. 2011, 80 (1): 17-28. 10.1038/ki.2010.483.CrossRefPubMed
25.
go back to reference Foundation NK: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266. Foundation NK: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266.
26.
go back to reference Pearce N: Analytical implications of epidemiological concepts of interaction. Int J Epidemiol. 1989, 18 (4): 976-980. 10.1093/ije/18.4.976.CrossRefPubMed Pearce N: Analytical implications of epidemiological concepts of interaction. Int J Epidemiol. 1989, 18 (4): 976-980. 10.1093/ije/18.4.976.CrossRefPubMed
27.
go back to reference MacIsaac RJ, Jerums G, Cooper ME: New insights into the significance of microalbuminuria. Curr Opin Nephrol Hypertens. 2004, 13 (1): 83-91. 10.1097/00041552-200401000-00012.CrossRefPubMed MacIsaac RJ, Jerums G, Cooper ME: New insights into the significance of microalbuminuria. Curr Opin Nephrol Hypertens. 2004, 13 (1): 83-91. 10.1097/00041552-200401000-00012.CrossRefPubMed
28.
go back to reference Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V: Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai urban rural epidemiology study (CURES 45). Diabetes Care. 2007, 30 (8): 2019-2024. 10.2337/dc06-2554.CrossRefPubMed Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V: Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai urban rural epidemiology study (CURES 45). Diabetes Care. 2007, 30 (8): 2019-2024. 10.2337/dc06-2554.CrossRefPubMed
29.
go back to reference Yokoyama H, Kawai K, Kobayashi M: Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan diabetes clinical data management study group (JDDM 10). Diabetes Care. 2007, 30 (4): 989-992. 10.2337/dc06-1859.CrossRefPubMed Yokoyama H, Kawai K, Kobayashi M: Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan diabetes clinical data management study group (JDDM 10). Diabetes Care. 2007, 30 (4): 989-992. 10.2337/dc06-1859.CrossRefPubMed
30.
go back to reference Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed
31.
go back to reference Lu B, Song X, Dong X, Yang Y, Zhang Z, Wen J, Li Y, Zhou L, Zhao N, Zhu X, Hu R: High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications. 2008, 22 (2): 96-103. 10.1016/j.jdiacomp.2007.08.001.CrossRefPubMed Lu B, Song X, Dong X, Yang Y, Zhang Z, Wen J, Li Y, Zhou L, Zhao N, Zhu X, Hu R: High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications. 2008, 22 (2): 96-103. 10.1016/j.jdiacomp.2007.08.001.CrossRefPubMed
32.
go back to reference Lin CH, Yang WC, Tsai ST, Tung TH, Chou P: A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract. 2007, 75 (3): 306-312. 10.1016/j.diabres.2006.06.028.CrossRefPubMed Lin CH, Yang WC, Tsai ST, Tung TH, Chou P: A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract. 2007, 75 (3): 306-312. 10.1016/j.diabres.2006.06.028.CrossRefPubMed
33.
go back to reference Safarinejad MR: The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol. 2009, 22 (1): 99-108.PubMed Safarinejad MR: The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol. 2009, 22 (1): 99-108.PubMed
34.
go back to reference Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009, 13 (6): 621-630. 10.1007/s10157-009-0199-x.CrossRefPubMed Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009, 13 (6): 621-630. 10.1007/s10157-009-0199-x.CrossRefPubMed
35.
go back to reference Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ: Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis. 2009, 53 (3 Suppl 3): S71-S77.CrossRefPubMed Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ: Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis. 2009, 53 (3 Suppl 3): S71-S77.CrossRefPubMed
36.
go back to reference Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW: Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006, 333 (7577): 1047-10.1136/bmj.39001.657755.BE.CrossRefPubMedPubMedCentral Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW: Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006, 333 (7577): 1047-10.1136/bmj.39001.657755.BE.CrossRefPubMedPubMedCentral
37.
go back to reference Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004, 66 (3): 920-923. 10.1111/j.1523-1755.2004.00837.x.CrossRefPubMed Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004, 66 (3): 920-923. 10.1111/j.1523-1755.2004.00837.x.CrossRefPubMed
38.
go back to reference Hemmelgarn BR, Culleton BF, Ghali WA: Derivation and validation of a clinical index for prediction of rapid progression of kidney dysfunction. QJM. 2007, 100 (2): 87-92.CrossRefPubMed Hemmelgarn BR, Culleton BF, Ghali WA: Derivation and validation of a clinical index for prediction of rapid progression of kidney dysfunction. QJM. 2007, 100 (2): 87-92.CrossRefPubMed
39.
go back to reference Jurkovitz CT, Qiu Y, Wang C, Gilbertson DT, Brown WW: The kidney early evaluation program (KEEP): program design and demographic characteristics of the population. Am J Kidney Dis. 2008, 51 (4 Suppl 2): S3-S12.CrossRefPubMed Jurkovitz CT, Qiu Y, Wang C, Gilbertson DT, Brown WW: The kidney early evaluation program (KEEP): program design and demographic characteristics of the population. Am J Kidney Dis. 2008, 51 (4 Suppl 2): S3-S12.CrossRefPubMed
40.
go back to reference James MT, Hemmelgarn BR, Tonelli M: Early recognition and prevention of chronic kidney disease. Lancet. 2010, 375 (9722): 1296-1309. 10.1016/S0140-6736(09)62004-3.CrossRefPubMed James MT, Hemmelgarn BR, Tonelli M: Early recognition and prevention of chronic kidney disease. Lancet. 2010, 375 (9722): 1296-1309. 10.1016/S0140-6736(09)62004-3.CrossRefPubMed
41.
go back to reference Coresh J, Stevens LA: Kidney function estimating equations: where do we stand?. Curr Opin Nephrol Hypertens. 2006, 15 (3): 276-284. 10.1097/01.mnh.0000222695.84464.61.CrossRefPubMed Coresh J, Stevens LA: Kidney function estimating equations: where do we stand?. Curr Opin Nephrol Hypertens. 2006, 15 (3): 276-284. 10.1097/01.mnh.0000222695.84464.61.CrossRefPubMed
42.
go back to reference Hallan S, Asberg A, Lindberg M, Johnsen H: Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004, 44 (1): 84-93. 10.1053/j.ajkd.2004.03.027.CrossRefPubMed Hallan S, Asberg A, Lindberg M, Johnsen H: Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004, 44 (1): 84-93. 10.1053/j.ajkd.2004.03.027.CrossRefPubMed
43.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17 (10): 2937-2944. 10.1681/ASN.2006040368.CrossRefPubMed Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17 (10): 2937-2944. 10.1681/ASN.2006040368.CrossRefPubMed
44.
go back to reference Liao Y, Liao W, Liu J, Xu G, Zeng R: Assessment of the CKD-EPI equation to estimate glomerular filtration rate in adults from a Chinese CKD population. J Int Med Res. 2011, 39 (6): 2273-2280. 10.1177/147323001103900624.CrossRefPubMed Liao Y, Liao W, Liu J, Xu G, Zeng R: Assessment of the CKD-EPI equation to estimate glomerular filtration rate in adults from a Chinese CKD population. J Int Med Res. 2011, 39 (6): 2273-2280. 10.1177/147323001103900624.CrossRefPubMed
45.
go back to reference Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003, 290 (23): 3101-3114. 10.1001/jama.290.23.3101.CrossRefPubMed Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR: Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003, 290 (23): 3101-3114. 10.1001/jama.290.23.3101.CrossRefPubMed
46.
go back to reference Vassalotti JA, Li S, Chen SC, Collins AJ: Screening populations at increased risk of CKD: the kidney early evaluation program (KEEP) and the public health problem. Am J Kidney Dis. 2009, 53 (3 Suppl 3): S107-S114.CrossRefPubMed Vassalotti JA, Li S, Chen SC, Collins AJ: Screening populations at increased risk of CKD: the kidney early evaluation program (KEEP) and the public health problem. Am J Kidney Dis. 2009, 53 (3 Suppl 3): S107-S114.CrossRefPubMed
47.
go back to reference American Diabetes Association: Standards of medical care in diabetes--2012. Diabetes Care. 2012, 35 Suppl 1: S11-S63. American Diabetes Association: Standards of medical care in diabetes--2012. Diabetes Care. 2012, 35 Suppl 1: S11-S63.
Metadata
Title
Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China
Authors
Yi Zhou
Justin B Echouffo-Tcheugui
Jian-jun Gu
Xiao-nan Ruan
Gen-ming Zhao
Wang-hong Xu
Li-ming Yang
Hong Zhang
Hua Qiu
K M Venkat Narayan
Qiao Sun
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-253

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.